Its mechanism of action involves two main aspects: first, by blocking the RAF/MEK/ERK signaling pathway, it directly inhibits tumor cell growth and proliferation; second, by suppressing VEGFR and PDGFR-mediated angiogenesis, it reduces tumor blood supply and indirectly inhibits tumor growth [51]. This evidence concerns the gene MAP2K7 and neoplasm.